243 related articles for article (PubMed ID: 38179984)
21. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.
Godfrey C; Clement E; Mein R; Brockington M; Smith J; Talim B; Straub V; Robb S; Quinlivan R; Feng L; Jimenez-Mallebrera C; Mercuri E; Manzur AY; Kinali M; Torelli S; Brown SC; Sewry CA; Bushby K; Topaloglu H; North K; Abbs S; Muntoni F
Brain; 2007 Oct; 130(Pt 10):2725-35. PubMed ID: 17878207
[TBL] [Abstract][Full Text] [Related]
22. Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan.
Stevens E; Carss KJ; Cirak S; Foley AR; Torelli S; Willer T; Tambunan DE; Yau S; Brodd L; Sewry CA; Feng L; Haliloglu G; Orhan D; Dobyns WB; Enns GM; Manning M; Krause A; Salih MA; Walsh CA; Hurles M; Campbell KP; Manzini MC; ; Stemple D; Lin YY; Muntoni F
Am J Hum Genet; 2013 Mar; 92(3):354-65. PubMed ID: 23453667
[TBL] [Abstract][Full Text] [Related]
23. Distinct functions of glial and neuronal dystroglycan in the developing and adult mouse brain.
Satz JS; Ostendorf AP; Hou S; Turner A; Kusano H; Lee JC; Turk R; Nguyen H; Ross-Barta SE; Westra S; Hoshi T; Moore SA; Campbell KP
J Neurosci; 2010 Oct; 30(43):14560-72. PubMed ID: 20980614
[TBL] [Abstract][Full Text] [Related]
24. A new monoclonal antibody DAG-6F4 against human alpha-dystroglycan reveals reduced core protein in some, but not all, dystroglycanopathy patients.
Humphrey EL; Lacey E; Le LT; Feng L; Sciandra F; Morris CR; Hewitt JE; Holt I; Brancaccio A; Barresi R; Sewry CA; Brown SC; Morris GE
Neuromuscul Disord; 2015 Jan; 25(1):32-42. PubMed ID: 25387694
[TBL] [Abstract][Full Text] [Related]
25. Hypoglycosylation of dystroglycan due to T192M mutation: a molecular insight behind the fact.
Bhattacharya S; Das A; Ghosh S; Dasgupta R; Bagchi A
Gene; 2014 Mar; 537(1):108-14. PubMed ID: 24361964
[TBL] [Abstract][Full Text] [Related]
26. Muscular dystrophies due to glycosylation defects.
Muntoni F; Torelli S; Brockington M
Neurotherapeutics; 2008 Oct; 5(4):627-32. PubMed ID: 19019316
[TBL] [Abstract][Full Text] [Related]
27. ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies.
Cirak S; Foley AR; Herrmann R; Willer T; Yau S; Stevens E; Torelli S; Brodd L; Kamynina A; Vondracek P; Roper H; Longman C; Korinthenberg R; Marrosu G; Nürnberg P; ; Michele DE; Plagnol V; Hurles M; Moore SA; Sewry CA; Campbell KP; Voit T; Muntoni F
Brain; 2013 Jan; 136(Pt 1):269-81. PubMed ID: 23288328
[TBL] [Abstract][Full Text] [Related]
28. [Congenital muscular dystrophy and alpha-dystroglycanopathy].
Saito F; Matsumura K; Hagiwara H; Shimizu T
Rinsho Shinkeigaku; 2008 Aug; 48(8):543-9. PubMed ID: 18939472
[TBL] [Abstract][Full Text] [Related]
29. [Pathomechanism and therapeutic strategy of Fukuyama congenital muscular dystrophy and related disorders].
Toda T
Rinsho Shinkeigaku; 2009 Nov; 49(11):859-62. PubMed ID: 20030231
[TBL] [Abstract][Full Text] [Related]
30. The zebrafish dag1 mutant: a novel genetic model for dystroglycanopathies.
Gupta V; Kawahara G; Gundry SR; Chen AT; Lencer WI; Zhou Y; Zon LI; Kunkel LM; Beggs AH
Hum Mol Genet; 2011 May; 20(9):1712-25. PubMed ID: 21296866
[TBL] [Abstract][Full Text] [Related]
31. Muscular Dystrophy with Ribitol-Phosphate Deficiency: A Novel Post-Translational Mechanism in Dystroglycanopathy.
Kanagawa M; Toda T
J Neuromuscul Dis; 2017; 4(4):259-267. PubMed ID: 29081423
[TBL] [Abstract][Full Text] [Related]
32. Absence of post-phosphoryl modification in dystroglycanopathy mouse models and wild-type tissues expressing non-laminin binding form of α-dystroglycan.
Kuga A; Kanagawa M; Sudo A; Chan YM; Tajiri M; Manya H; Kikkawa Y; Nomizu M; Kobayashi K; Endo T; Lu QL; Wada Y; Toda T
J Biol Chem; 2012 Mar; 287(12):9560-7. PubMed ID: 22270369
[TBL] [Abstract][Full Text] [Related]
33. Defective peripheral nerve myelination and neuromuscular junction formation in fukutin-deficient chimeric mice.
Saito F; Masaki T; Saito Y; Nakamura A; Takeda S; Shimizu T; Toda T; Matsumura K
J Neurochem; 2007 Jun; 101(6):1712-22. PubMed ID: 17326765
[TBL] [Abstract][Full Text] [Related]
34. Four-week rapamycin treatment improves muscular dystrophy in a fukutin-deficient mouse model of dystroglycanopathy.
Foltz SJ; Luan J; Call JA; Patel A; Peissig KB; Fortunato MJ; Beedle AM
Skelet Muscle; 2016; 6():20. PubMed ID: 27257474
[TBL] [Abstract][Full Text] [Related]
35. In-silico structural analysis of E509K mutation in LARGE and T192M mutation in Alpha Dystroglycan in the inhibition of glycosylation of Alpha Dystroglycan by LARGE.
Bhattacharya S; Das A; Bagchi A
Comput Biol Chem; 2016 Oct; 64():313-321. PubMed ID: 27565399
[TBL] [Abstract][Full Text] [Related]
36. biAb Mediated Restoration of the Linkage between Dystroglycan and Laminin-211 as a Therapeutic Approach for α-Dystroglycanopathies.
Gumlaw N; Sevigny LM; Zhao H; Luo Z; Bangari DS; Masterjohn E; Chen Y; McDonald B; Magnay M; Travaline T; Yoshida-Moriguchi T; Fan W; Reczek D; Stefano JE; Qiu H; Beil C; Lange C; Rao E; Lukason M; Barry E; Brondyk WH; Zhu Y; Cheng SH
Mol Ther; 2020 Feb; 28(2):664-676. PubMed ID: 31843448
[TBL] [Abstract][Full Text] [Related]
37. Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies.
Chan YM; Keramaris-Vrantsis E; Lidov HG; Norton JH; Zinchenko N; Gruber HE; Thresher R; Blake DJ; Ashar J; Rosenfeld J; Lu QL
Hum Mol Genet; 2010 Oct; 19(20):3995-4006. PubMed ID: 20675713
[TBL] [Abstract][Full Text] [Related]
38. The Structure of the T190M Mutant of Murine α-Dystroglycan at High Resolution: Insight into the Molecular Basis of a Primary Dystroglycanopathy.
Bozzi M; Cassetta A; Covaceuszach S; Bigotti MG; Bannister S; Hübner W; Sciandra F; Lamba D; Brancaccio A
PLoS One; 2015; 10(5):e0124277. PubMed ID: 25932631
[TBL] [Abstract][Full Text] [Related]
39. Genetic Engineering of Dystroglycan in Animal Models of Muscular Dystrophy.
Sciandra F; Bigotti MG; Giardina B; Bozzi M; Brancaccio A
Biomed Res Int; 2015; 2015():635792. PubMed ID: 26380289
[TBL] [Abstract][Full Text] [Related]
40. Post-translational maturation of dystroglycan is necessary for pikachurin binding and ribbon synaptic localization.
Kanagawa M; Omori Y; Sato S; Kobayashi K; Miyagoe-Suzuki Y; Takeda S; Endo T; Furukawa T; Toda T
J Biol Chem; 2010 Oct; 285(41):31208-16. PubMed ID: 20682766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
